Profile
Seiichi Murakami is currently a Director at Medicago, Inc. He was previously a Director at Mitsubishi Tanabe Pharma Corp.
from 1980 to 2019.
Seiichi Murakami active positions
| Companies | Position | Start |
|---|---|---|
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Director/Board Member | 2013-09-17 |
Former positions of Seiichi Murakami
| Companies | Position | End |
|---|---|---|
| MITSUBISHI TANABE PHARMA CORPORATION | Director/Board Member | 2019-06-20 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
- Stock Market
- Insiders
- Seiichi Murakami
